ArticleInfection2019

HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?

Linda Drößler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.